RE: Sleeping 😴21 Jan 2026 11:34
Marty
You are clearly heavily invested here. This can affect your objectivity about a stock and its potential.
The only thing we have to hold the company to account is their statement that it ‘expects to achieve high-single digit revenue growth in 2026’
That places us where we are.
We would need exceptional news (such as Iliad obtaining the required funding for the phase 3 Hvivo trial) to shift the price significantly from here. This may of course happen but as it’s outside of the company’s control, no amount of pressure or criticism of the board will help.
As for other contracts, we know there are others in the pipeline (at least two in the final stages of negotiation), which could also land any time.
For info, the FTSE was down less that 1% on Monday.